𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Immunoreactive prolyl hydroxylase in patients with primary and secondary myelofibrosis

✍ Scribed by Jen C. Wang; Ching WonC Winston; Whei-Yang Kao

Book ID
114711114
Publisher
John Wiley and Sons
Year
1987
Tongue
English
Weight
362 KB
Volume
65
Category
Article
ISSN
0007-1048

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Pulmonary hypertension in patients with
Pulmonary hypertension in patients with myelofibrosis secondary to myeloproliferative diseases
✍ GarcοΏ½a-Manero, Guillermo; Schuster, Stephen J.; Patrick, Herbert; Martinez, JosοΏ½ πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 35 KB πŸ‘ 1 views

We examined the clinical characteristics of six patients with myelofibrosis secondary to myeloproliferative diseases whose clinical courses were complicated by pulmonary hypertension to determine possible causal links between the two disorders. Six patients (four male, two female), with diagnoses of

Risk factors for leukemic transformation
Risk factors for leukemic transformation in patients with primary myelofibrosis
✍ Jocelin Huang; Chin-Yang Li; Ruben A. Mesa; Wentling Wu; Curtis A. Hanson; Anime πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 132 KB

## Abstract ## BACKGROUND. Previous prognostic studies in primary myelofibrosis have focused on risk factors for overall survival and have resulted in the establishment of several prognostic scoring systems. However, to the authors' knowledge, information regarding risk factors for leukemic transf